Back to search

Article

Pathogenicity assessment of a TSC2 c.2966+1G>A splice site variant in vaginal adenocarcinoma

2026-01-16

Abstract excerpt

<h4>ABSTRACT</h4> Clinical sequencing of a vaginal adenocarcinoma specimen yielded a reported TSC2 variant which was classified as splice-modulating loss-of-function, prompting consideration of a clinical trial for tumors with TSC2 loss. Literature review suggested that germline alterations affecting this particular exon are considered non-pathogenic, raising concern about the initial somatic variant interpretati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e3137f8-cf28-5249-81fe-419a3e1cc2e8
DOI
10.64898/2025.12.31.25343109
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pathogenicity assessment of a TSC2 c.2966+1G>A splice site variant in vaginal adenocarcinomaDOI 10.64898/2025.12.31.25343109
Select a neighboring publication to make it the new centre.